We’re thrilled to share a vital new resource for everyone living with ALK-positive non-small cell lung cancer!

We believe this will be highly valuable for our community members and patients living with ALK-positive non-small cell lung cancer.

The publication, “Managing lorlatinib together: An overview and practical guide for patients by ALK-positive NSCLC patients and medical experts,” also serves as an inspiration for us for true partnership between patients who have lived the experience and leading medical experts from around the globe.

This comprehensive guide brings together real-life insight with clinical expertise to support you on your journey.

What’s inside this essential guide?

The guide is packed with practical, actionable information, including:

• Practical information about what to expect from lorlatinib treatment.
• Evidence-based strategies for managing side effects.
• Key questions patients should ask their healthcare teams.
• A patient-friendly timeline of potential side effects.
• Guidance on maintaining quality of life during treatment.